reported a large insider buy on May 10, 2023 according to the SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission showed that Platt purchased 6.76M shares of Bioxytran. The total amounted to $2.16M https://www.benzinga.com/news/23/05/32344359/...quote_news